Agilent Technologies, Inc. $A Stock Position Raised by Carmel Capital Partners LLC

Carmel Capital Partners LLC lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 32.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,928 shares of the medical research company’s stock after buying an additional 2,667 shares during the period. Carmel Capital Partners LLC’s holdings in Agilent Technologies were worth $1,290,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Verdence Capital Advisors LLC boosted its stake in Agilent Technologies by 5.0% during the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock valued at $215,000 after purchasing an additional 86 shares during the period. Valeo Financial Advisors LLC boosted its stake in Agilent Technologies by 3.0% during the 1st quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company’s stock valued at $403,000 after purchasing an additional 102 shares during the period. Cary Street Partners Financial LLC boosted its stake in Agilent Technologies by 2.9% during the 1st quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock valued at $431,000 after purchasing an additional 103 shares during the period. Bartlett & CO. Wealth Management LLC boosted its stake in Agilent Technologies by 5.1% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company’s stock valued at $281,000 after purchasing an additional 116 shares during the period. Finally, Stratos Wealth Partners LTD. boosted its stake in Agilent Technologies by 0.3% during the 1st quarter. Stratos Wealth Partners LTD. now owns 41,334 shares of the medical research company’s stock valued at $4,835,000 after purchasing an additional 124 shares during the period.

Wall Street Analyst Weigh In

A has been the subject of a number of analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. TD Cowen boosted their target price on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research note on Tuesday. UBS Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and upped their price target for the stock from $130.00 to $170.00 in a research note on Wednesday, October 8th. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target for the company. Finally, Wells Fargo & Company upped their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research note on Monday, September 15th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $149.62.

Agilent Technologies Trading Up 0.6%

Shares of NYSE:A opened at $142.01 on Friday. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The firm has a market cap of $40.26 billion, a P/E ratio of 33.34, a P/E/G ratio of 4.61 and a beta of 1.26. The company has a 50 day moving average of $127.58 and a 200-day moving average of $117.83. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the business earned $1.32 earnings per share. The business’s quarterly revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.